We provide you with 20 years of free, institutional-grade data for GLUE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GLUE. Explore the full financial landscape of GLUE stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Dunn Edmund | Initial | 2023-08-18 | |||
| Makhzoumi Mohamad | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| Florence Anthony A. Jr. | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| Landsman Liza | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| Chang Carmen | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| New Enterprise Associates 17, L.P. | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| Behbahani Ali | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| BASKETT FOREST | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| Bolzon Bradley J PhD | Open Market Purchase | 157,895 | $19 | 2021-06-30 | |
| Versant Venture Capital VI, L.P. | Open Market Purchase | 157,895 | $19 | 2021-06-30 | |
| Cormorant Asset Management, LP | Open Market Purchase | 600,000 | $19 | 2021-06-30 | |
| SANDELL SCOTT D | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| Mathers Edward T | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| Sonsini Peter W. | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| MAKOWER JOSHUA | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| Yang Rick | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| Walker Paul Edward | Open Market Purchase | 1,050,000 | $19 | 2021-06-30 | |
| Castle John C. | Initial | 2021-06-23 | |||
| Warmuth Markus | Initial | 2021-06-23 | |||
| Versant Venture Capital VI, L.P. | Initial | 2021-06-23 |
The information provided in this report about GLUE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Monte Rosa Therapeutics Inc(NASDAQ:GLUE) 
Share this website to your friends